State Street Corp Allakos Inc. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Allakos Inc. stock. As of the latest transaction made, State Street Corp holds 247,975 shares of ALLK stock, worth $158,704. This represents 0.0% of its overall portfolio holdings.

Number of Shares

247,975

Previous 1,405,187 82.35%

Holding current value

$158,704

Previous $1.77 Million 86.05%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.0 - $1.45 $1.16 Million - $1.68 Million	-1,157,212 Reduced 82.35%	247,975 $247,000
Q1 2024 May 15, 2024	BUY	$1.02 - $3.23 $22,240 - $70,426	21,804 Added 1.58%	1,405,187 $1.77 Million
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.18 $127,061 - $234,916	-73,873 Reduced 5.07%	1,383,383 $3.78 Million
Q3 2023 Nov 14, 2023	SELL	$2.13 - $5.55 $6.22 Million - $16.2 Million	-2,918,262 Reduced 66.7%	1,457,256 $3.31 Million
Q2 2023 Aug 14, 2023	BUY	$3.6 - $5.25 $1.97 Million - $2.88 Million	548,316 Added 14.33%	4,375,518 $19.1 Million
Q1 2023 May 15, 2023	BUY	$4.3 - $8.27 $1.52 Million - $2.92 Million	353,451 Added 10.17%	3,827,202 $17 Million
Q4 2022 Feb 14, 2023	BUY	$5.66 - $8.42 $18.5 Million - $27.6 Million	3,274,476 Added 1643.19%	3,473,751 $29.2 Million
Q3 2022 Nov 15, 2022	BUY	$3.02 - $6.12 $226,264 - $458,522	74,922 Added 60.25%	199,275 $1.22 Million
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $1.71 Million - $4.05 Million	-659,200 Reduced 84.13%	124,353 $389,000
Q1 2022 May 16, 2022	SELL	$5.08 - $9.81 $3.3 Million - $6.38 Million	-649,978 Reduced 45.34%	783,553 $4.47 Million
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $2.2 Million - $28.8 Million	257,014 Added 21.85%	1,433,531 $14 Million
Q3 2021 Nov 15, 2021	BUY	$76.53 - $110.43 $4.49 Million - $6.48 Million	58,646 Added 5.25%	1,176,517 $125 Million
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $19.2 Million - $25.7 Million	225,146 Added 25.22%	1,117,871 $95.4 Million
Q1 2021 May 17, 2021	SELL	$109.73 - $153.66 $3.13 Million - $4.39 Million	-28,565 Reduced 3.1%	892,725 $102 Million
Q4 2020 Feb 16, 2021	SELL	$79.58 - $152.45 $5.33 Million - $10.2 Million	-66,993 Reduced 6.78%	921,290 $129 Million
Q3 2020 Nov 10, 2020	SELL	$66.43 - $90.99 $12.9 Million - $17.7 Million	-194,513 Reduced 16.45%	988,283 $80.5 Million
Q2 2020 Aug 14, 2020	BUY	$44.04 - $80.69 $16.4 Million - $30.1 Million	372,643 Added 46.0%	1,182,796 $85 Million
Q1 2020 May 11, 2020	BUY	$44.49 - $93.39 $36 Million - $75.7 Million	810,153 New	810,153 $36 Million

Others Institutions Holding ALLK

# of Institutions

104

Shares Held

70.7M

Call Options Held

43.8K

Put Options Held

1.4K

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $54.2M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Allakos Inc. Transaction History